Home › Melanoma › California › Mountain View

Pag-aaral pangklinika para sa Melanoma sa Mountain View, CA

Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Mountain View. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06060613

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi ang layo

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Nagre-recruitPhase 2

Stanford University, Palo Alto · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06712927

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Nagre-recruitPhase 1/2

Stanford Cancer Institute, Stanford · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Nagre-recruitPhase 3

Stanford Comprehensive Cancer Center, Palo Alto · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07015190

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Nagre-recruitPhase 2/3

Stanford, Stanford · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06624644

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Nagre-recruitPhase 2/3

Stanford Cancer Institute, Palo Alto · 5 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Nagre-recruitPhase 1

Stanford Cancer Institute, Stanford · 5 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04119024

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Stanford · 5 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Nagre-recruit

Stanford Cancer Institute, Palo Alto · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 27, 2024 · NCT03860883

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Nagre-recruitPhase 1

Stanford University, Stanford · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 8, 2024 · NCT04282044

Pag-aaral para sa Melanoma sa ibang lungsod

Iba pang pag-aaral sa Mountain View

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.